Showing results (211-220 of 340) with videos related to

Sort By:
Pageof 34
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2016
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR AnalysisEmma C Scott, Parameswaran Hari, Manish Sharma, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2017
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research ReportPooja Khandelwal, Heather R Millard, Elizabeth Thiel, et al.
Transplantation and Cellular Therapy|March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Transplantation and Cellular Therapy|December 30, 2025
Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults with Acute Myeloid Leukemia: A CIBMTR ReportHemalatha G Rangarajan, Deepakbabu Chellapandian, Rasha Atshan, et al.
Transplantation and Cellular Therapy|June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall SurvivalGurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemiaMouhab Ayas, Wael Saber, Stella M Davies, et al.
Pageof 34